Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors: A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (GITMO).

Adolescent Adult Aged Allografts Disease-Free Survival Female Hematopoietic Stem Cell Transplantation Humans Italy / epidemiology Male Middle Aged Philadelphia Chromosome Precursor Cell Lymphoblastic Leukemia-Lymphoma / mortality Registries Societies, Medical Survival Rate
Allogeneic hematopoietic stem cell transplantation Philadelphia chromosome-positive acute lymphoblastic leukemia Tyrosine kinase inhibitor

Journal

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
ISSN: 1523-6536
Titre abrégé: Biol Blood Marrow Transplant
Pays: United States
ID NLM: 9600628

Informations de publication

Date de publication:
12 2019
Historique:
received: 10 06 2019
revised: 22 07 2019
accepted: 26 07 2019
pubmed: 11 8 2019
medline: 9 9 2020
entrez: 11 8 2019
Statut: ppublish

Résumé

We performed a nationwide registry-based analysis to describe the clinical outcome of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph

Identifiants

DOI: 10.1016/j.bbmt.2019.07.037 PMID: 31400502
pubmed: 31400502
pii: S1083-8791(19)30509-9
doi: 10.1016/j.bbmt.2019.07.037
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT03821727']

Types de publication

Clinical Trial Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

2388-2397

Informations de copyright

Copyright © 2019. Published by Elsevier Inc.

Auteurs

Anna Candoni (A)

Hematology and SCT Unit, Università di Udine, Azienda Sanitaria-Universitaria Integrata Santa Maria Misericordia, Udine, Italy. Electronic address: anna.candoni@asuiud.sanita.fvg.it.

Alessandro Rambaldi (A)

Department of Oncology-Hematology, Universita' degli Studi di Milano e Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy.

Renato Fanin (R)

Hematology and SCT Unit, Università di Udine, Azienda Sanitaria-Universitaria Integrata Santa Maria Misericordia, Udine, Italy.

Andrea Velardi (A)

Hematology and Clinical Immunology, Università di Perugia, Perugia, Italy.

William Arcese (W)

Rome Transplant Network, Università Tor Vergata, Roma, Italy.

Fabio Ciceri (F)

Hematology and BMT Unit, San Raffaele Scientific Institute, University Vita-Salute San Raffaele, Milano, Italy.

Davide Lazzarotto (D)

Hematology and SCT Unit, Università di Udine, Azienda Sanitaria-Universitaria Integrata Santa Maria Misericordia, Udine, Italy.

Federico Lussana (F)

Department of Oncology-Hematology, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Bergamo, Italy.

Jacopo Olivieri (J)

Hematology and SCT Unit, Università di Udine, Azienda Sanitaria-Universitaria Integrata Santa Maria Misericordia, Udine, Italy.

Giovanni Grillo (G)

Department of Hematology Oncology, Ospedale Niguarda Ca' Granda, Milano, Italy.

Matteo Parma (M)

Clinica Ematologica e Centro Trapianto di Midollo, Ospedale San Gerardo, Monza, Italy.

Benedetto Bruno (B)

Dipartimento di Biotecnologie Molecolari e Scienze per la Salute, Università di Torino,Torino, Italy; Dipartimento di Oncologia, Presidio Molinette-AOU Città della Salute e della Scienza, Trapianto Allogenico di Cellule Staminali, Torino, Italy.

Federica Sora (F)

Istituto di Ematologia, Fondazione Policlinico Universitario A. Gemelli, Roma, Italy.

Paolo Bernasconi (P)

Centro Trapianti SC Ematologia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Riccardo Saccardi (R)

Centro Trapianti di Midollo Osseo, Careggi University Hospital, Firenze, Italy.

Robin Foà (R)

Hematology, Department of Translational and Precision Medicine, Sapienza University, Policlinico Umberto I, Roma, Italy.

Mariarosa Sessa (M)

Institute of Hematology L. and A. Seragnoli, University Hospital S. Orsola-Malpighi, Bologna, Italy.

Paola Bresciani (P)

Section of Hematology, University of Modena and Reggio Emilia, Modena, Italy.

Fabio Giglio (F)

Hematology and BMT Unit, San Raffaele Scientific Institute, University Vita-Salute San Raffaele, Milano, Italy.

Alessandra Picardi (A)

Rome Transplant Network, Università Tor Vergata, Roma, Italy.

Alessandro Busca (A)

Dipartimento di Oncologia, Presidio Molinette-AOU Città della Salute e della Scienza, Trapianto Allogenico di Cellule Staminali, Torino, Italy.

Simona Sica (S)

Istituto di Ematologia, Fondazione Policlinico Universitario A. Gemelli, Roma, Italy.

Katia Perruccio (K)

Hematology and Clinical Immunology, Università di Perugia, Perugia, Italy.

Elisa Zucchetti (E)

Department of Hematology Oncology, Ospedale Niguarda Ca' Granda, Milano, Italy.

Elisa Diral (E)

Clinica Ematologica e Centro Trapianto di Midollo, Ospedale San Gerardo, Monza, Italy.

Anna Paola Iori (AP)

Hematology, Department of Translational and Precision Medicine, Sapienza University, Policlinico Umberto I, Roma, Italy.

Anna Amelia Colombo (AA)

Centro Trapianti SC Ematologia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Stefano Tringali (S)

UOS Trapianto di Midollo, AOR Villa Sofia-Cervello, Palermo, Italy.

Stella Santarone (S)

Dipartimento di Ematologia, Medicina Trasfusionale e Biotecnologie, Ospedale Civile, Pescara, Italy.

Giuseppe Irrera (G)

Centro Unico Regionale Trapianto Cellule Staminali e Terapie Cellulari A. Neri, Grande Ospedale Metropolitano Bianchi-Melacrino-Morelli, Reggio Calabria, Italy.

Stefano Mancini (S)

Centro Trapianti di Cellule Staminali, Azienda Ospedaliera San Camillo Forlanini, Roma, Italy.

Francesco Zallio (F)

Unità Trapianti Midollo, Azienda Ospedaliera S. Antonio e Biagio, Alessandria, Italy.

Michele Malagola (M)

Unit of Blood Diseases and Stem Cell Transplantation, University of Brescia, ASST-Spedali Civili, Brescia, Italy.

Francesco Albano (F)

Dipartimento Emergenza e Trapianti di Organi, University of Bari, Bari, Italy.

Angelo Michele Carella (AM)

UO Ematologia e Centro Trapianti TMO, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.

Attilio Olivieri (A)

Hematology and Bone Marrow Transplantation, University of Marche-Ospedali Riuniti, Ancona, Italy.

Cristina Tecchio (C)

Hematology-Bone Marrow Transplant Unit, University of Verona, Verona, Italy.

Alida Dominietto (A)

UO Ematologia e Centro Trapianti, IRCCS Ospedale Policlinico San Martino, Genova, Italy.

Adriana Vacca (A)

UO Ematologia-CTMO, PO Roberto Binaghi, Cagliari, Italy.

Roberto Sorasio (R)

SC Ematologia, Azienda Ospedaliera S Croce e Carle, Cuneo, Italy.

Enrico Orciuolo (E)

UO Ematologia, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.

Antonio Maria Risitano (AM)

BMT Unit, Department of Clinical Medicine and Surgery, Università di Napoli, Napoli, Italy.

Salvatore Leotta (S)

Programma di Trapianto Emopoietico, Azienda Policlinico-Vittorio Emanuele, Catania, Italy.

Agostino Cortelezzi (A)

Università degli Studi e Ospedale Maggiore Policlinico di Milano, Milano, Italy.

Sonia Mammoliti (S)

GITMO Clinical Trials Office, Genova, Italy.

Elena Oldani (E)

Department of Oncology-Hematology, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Bergamo, Italy.

Francesca Bonifazi (F)

Institute of Hematology L. and A. Seragnoli, University Hospital S. Orsola-Malpighi, Bologna, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adolescent › Outcome of Allogeneic Hematopoietic Stem Cell...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Outcome of Allogeneic Hematopoietic Stem Cell...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › Outcome of Allogeneic Hematopoietic Stem Cell...
questionsmedicales.fr › Régions du corps › Transplants › Allogreffes › Outcome of Allogeneic Hematopoietic Stem Cell...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Analyse de survie › Survie sans rechute › Outcome of Allogeneic Hematopoietic Stem Cell...
questionsmedicales.fr › Procédures de chirurgie opératoire › Transplantation › Transplantation cellulaire › Transplantation de cellules souches › Transplantation de cellules souches hématopoïétiques › Outcome of Allogeneic Hematopoietic Stem Cell...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Outcome of Allogeneic Hematopoietic Stem Cell...
questionsmedicales.fr › Régions géographiques › Europe › Italie › Outcome of Allogeneic Hematopoietic Stem Cell...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Adulte d'âge moyen › Outcome of Allogeneic Hematopoietic Stem Cell...
questionsmedicales.fr › Phénomènes génétiques › Variation génétique › Mutation › Aberrations des chromosomes › Chromosome Philadelphie › Outcome of Allogeneic Hematopoietic Stem Cell...
questionsmedicales.fr › Maladies du système immunitaire › Syndromes immunoprolifératifs › Syndromes lymphoprolifératifs › Leucémie lymphoïde › Leucémie-lymphome lymphoblastique à précurseurs B et T › Outcome of Allogeneic Hematopoietic Stem Cell...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Collecte de données › Enregistrements › Outcome of Allogeneic Hematopoietic Stem Cell...
questionsmedicales.fr › Organisations et économie des soins de santé › Organismes › Sociétés › Sociétés médicales › Outcome of Allogeneic Hematopoietic Stem Cell...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Collecte de données › Registre civil › Mortalité › Taux de survie › Outcome of Allogeneic Hematopoietic Stem Cell...